Cargando…
In Vitro Antimalarial Activity of Inhibitors of the Human GTPase Rac1
Malaria accounts for millions of cases and thousands of deaths every year. In the absence of an effective vaccine, drugs are still the most important tool in the fight against the disease. Plasmodium parasites developed resistance to all classes of known antimalarial drugs. Thus, the search for anti...
Autores principales: | Parapini, Silvia, Paone, Silvio, Erba, Emanuela, Cavicchini, Loredana, Pourshaban, Manoochehr, Celani, Francesco, Contini, Alessandro, D’Alessandro, Sarah, Olivieri, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8765435/ https://www.ncbi.nlm.nih.gov/pubmed/34723630 http://dx.doi.org/10.1128/AAC.01498-21 |
Ejemplares similares
-
Characterization of the erythrocyte GTPase Rac1 in relation to Plasmodium falciparum invasion
por: Paone, Silvio, et al.
Publicado: (2020) -
Role of Host Small GTPases in Apicomplexan Parasite Infection
por: Paone, Silvio, et al.
Publicado: (2022) -
A role for the small GTPase Rac1 in vaccinia actin-based motility
por: Alvarez, Diego E, et al.
Publicado: (2015) -
Population Pharmacokinetics of Tafenoquine, a Novel Antimalarial
por: Thakkar, Nilay, et al.
Publicado: (2018) -
Preclinical Antimalarial Combination Study of M5717, a Plasmodium falciparum Elongation Factor 2 Inhibitor, and Pyronaridine, a Hemozoin Formation Inhibitor
por: Rottmann, Matthias, et al.
Publicado: (2020)